Apr 26, 2024
In a remarkable decision posted earlier this month, INESSS stands alone in failing to recognize the therapeutic value of XPOVIO. This despite Health Canada approval, a positive CADTH decision, Quebec clinician and patient support and positive funding recommendations...
Apr 10, 2024
FORUS Therapeutics is pleased to announce that XPOVIO® (selinexor) is now publicly funded in PEI as of April 23rd. Please see the following links for full funding criteria: PEI Pharmacare Bulletin – Pharmacist Bulletin – April 09, 2024 We are excited about these...
Recent Comments